Literature DB >> 1302808

Synergistic interaction of miconazole and fluconazole at sub-MIC level on Candida albicans.

Y Mikami1, A Takahashi, K Yazawa, K Terao, Y Ueno.   

Abstract

The in vitro combination effect of two azole antimycotics, miconazole and fluconazole, against Candida albicans was studied. When minimum (MIC) and sub-minimum (sub-MIC) inhibitory concentration and fractional inhibitory concentration (FIC) determinations were made, a synergistic interaction of the two agents at the concentration well below their individual MICs (at sub-MIC levels) was evidenced. The FIC index values ranged from 0.3 to 1.0 and the synergy was characterized by the potentiation of fluconazole activity with miconazole. The synergistic effect was also confirmed by a turbidometric method. On the other hand, such a synergistic effect against Candida krusei was not confirmed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302808     DOI: 10.1111/j.1439-0507.1992.tb00888.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  In vitro interaction between amphotericin B and azoles in Candida albicans.

Authors:  J A Vazquez; M T Arganoza; J K Vaishampayan; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.

Authors:  Keigo Kimura; Yoshitsugu Inoue; Seishi Asari; Atsuko Sunada; Yuichi Ohashi; Yoshikazu Shimomura; Chie Sotozono; Hiroshi Hatano; Masahiko Fukuda; Hiroshi Eguchi; Kaoru Araki-Sasaki; Takashi Suzuki; Saichi Hoshi; Toru Tobe; Takashi Yaguchi; Koichi Makimura
Journal:  Jpn J Ophthalmol       Date:  2022-03-29       Impact factor: 2.447

3.  Miconazole-Urea in a Buccal Film as a New Trend for Treatment of Resistant Mouth Fungal White Patches.

Authors:  Omar Y Mady; Ahmed M Donia; Lamiaa A Al-Madboly
Journal:  Front Microbiol       Date:  2018-05-11       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.